Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer [Phase 3]
Phase 3 trial update for GB491 in combination with letrozole in HR-positive, HER2-negative advanced breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial update evaluating trastuzumab emtansine in Chinese patients with HER2-positive locally advanced or metastatic breast cancer ha…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE [Phase 2]
Phase 2 trial of RTA 408 Lotion in breast cancer patients at risk for radiation dermatitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Compare Outcomes Between Two Acellular Dermal Matrices [Phase 2]
Phase 2 clinical trial comparing outcomes between two acellular dermal matrices in breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating letrozole in combination with sorafenib for metastatic breast cancer has completed with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer. [Phase 3]
Phase 3 trial comparing Carelizumab plus nab-paclitaxel with/apatinib, Carelizumab plus nab-paclitaxel, and nab-paclitaxel in advanced tripl…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating SHR6390 with Pyrotinib for HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Breast Cancer - Anti-Progestin Prevention Study 1 [Phase 2]
Phase 2 clinical trial update for anti-progestin prevention in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer [Phase 3]
Phase 3 trial evaluating adjuvant pyrotinib in combination with trastuzumab for HER2-positive invasive breast cancer; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Comparing the Perioperative Analgesic Effect of Two Different Volumes of Local Anesthetic Solution in Erector Spinae Plane Block in Patients Undergoing Modified Radical Mastectomy [Phase 2, Phase 3]
Phase 2/3 trial comparing two volumes of local anesthetic for erector spinae plane block in patients undergoing modified radical mastectomy;…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: IGF Level in Breast Cancer Patients Treated With Metformin [Phase 4]
Phase 4 clinical trial update investigating IGF level changes in breast cancer patients treated with metformin.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer [Phase 4]
Phase 4 trial comparing intravenous versus oral 5-HT3 antagonists combined with NK-1 receptor antagonists for prevention of chemotherapy-ind…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Intraoperative Detection of Residual Cancer in Breast Cancer [Phase 2]
Phase 2 clinical trial updating on intraoperative detection of residual cancer in breast cancer; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia [Phase 4]
Phase 4 trial update reporting long-term outcomes after wound infiltration analgesia in breast cancer surgery patients, focusing on postoper…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
A combined Phase 1/2 study investigates epothilone D with Herceptin (trastuzumab) in HER-2 positive advanced or metastatic breast cancer; st…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Breast Cancer Study of Preoperative Pembrolizumab + Radiation [Phase 1, Phase 2]
Update on a breast cancer trial evaluating preoperative pembrolizumab with radiation across Phase 1 and Phase 2, with results posted and the…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients [Phase 2]
Phase 2 trial update evaluating second-line therapy with ERIbulin followed by capecitabine or the reverse sequence in HER2-negative metastat…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery [Phase 2]
Phase 2 trial update on targeted T cells after neoadjuvant chemotherapy in women with stage II or III breast cancer undergoing surgery has b…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks [Phase 3]
Phase 3 trial update assessing efficacy of capecitabine as adjuvant therapy in high-risk HR+/HER2- breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: ANG1005 in Leptomeningeal Disease From Breast Cancer [Phase 3]
Phase 3 clinical trial update for ANG1005 in leptomeningeal disease from breast cancer (leptomeningeal carcinomatosis/metastases).
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating accelerated radiation therapy after surgery for breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: 99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes [Phase 2]
Phase 2 clinical trial evaluating 99mTc-ADAPT6 SPECT imaging to quantify HER2-expression non-invasively in breast cancer with metastatic lym…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating memantine to prevent cognitive decline in patients experiencing chemo-brain/Cognitive Decline after breast cancer t…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA) [Phase 2]
Phase 2 neoadjuvant trial evaluating palbociclib with endocrine therapy in ER-positive/HER2-negative breast cancer has completed.